-
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today published its inaugural Environmental, Social and Governance (ESG) report highlighting the company’s corporate responsibility and sustainability initiatives.AtriCure’s 2021 ESG Report showcases several of the company’s recent ESG accomplishments, including:Achieving gender parity on the Board of Di
-
Health system to donate $1.5 million as part of commitment to expanding partnerships with HBCUs and HSIs